| ürün Ad? |
Alfuzosine Hydrochloride |
| ingilizce ad? |
Alfuzosine Hydrochloride; alfuzosinehydrochloride; SL-77,499-10; MITTOVAL; N-[3-[(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLYNYL)METHYLAMINO]PROPYL]TETRAHYDRO-2-FURANCARBOXAMIDE; XATRAL; URION; UROXANTRAL; ALFUZOSIN HCL; ALFUZOSIN HYDROCHLORIDE; N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide, SL-77,499-10, Mittoval, Urion, Xatral; 2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-, hydrochloride; N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride; Uroxatral hydrochloride, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-; furancarboxamide hydrochloride; N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]oxol
ane-2-carboxamide; 2-Furancarboxamide; N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methyl
amino)propyl)tetrahydro-; Alfuzosina [Spanish]; Alfuzosine [French]; Alfuzosinum [Latin]; HSDB 7290; KBio3_001866; KBioGR_001616; N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahy
dro-2-furancarboxamide; Prestwick0_000322; Prestwick1_000322; SL 77499; SPBio_000429; SPBio_002244; Spectrum2_000505; Spectrum3_001063; Spectrum4_001208; N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide hydrochloride (1:1) |
| Moleküler Formülü |
C19H28ClN5O4 |
| Molekül A??rl??? |
425.9097 |
| InChI |
InChI=1/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H |
| CAS kay?t numaras? |
81403-68-1 |
| Moleküler Yap?s? |
|
| Ergime noktas? |
225℃ |
| Kaynama noktas? |
687.7°C at 760 mmHg |
| Alevlenme noktas? |
369.7°C |
| Buhar bas?nc? |
3.75E-19mmHg at 25°C |
|
TR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
